1. Home
  2. SITC vs ABCL Comparison

SITC vs ABCL Comparison

Compare SITC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SITE Centers Corp.

SITC

SITE Centers Corp.

N/A

Current Price

$5.86

Market Cap

348.9M

Sector

Real Estate

ML Signal

N/A

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$3.50

Market Cap

910.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SITC
ABCL
Founded
1965
2012
Country
United States
Canada
Employees
172
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
348.9M
910.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SITC
ABCL
Price
$5.86
$3.50
Analyst Decision
Hold
Buy
Analyst Count
3
5
Target Price
$10.83
$7.75
AVG Volume (30 Days)
711.6K
3.0M
Earning Date
01-01-0001
05-26-2026
Dividend Yield
114.60%
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.59
P/E Ratio
$12.09
N/A
Revenue Growth
N/A
160.56
52 Week Low
$5.83
$1.89
52 Week High
$13.27
$6.52

Technical Indicators

Market Signals
Indicator
SITC
ABCL
Relative Strength Index (RSI) 30.70 49.86
Support Level N/A $3.37
Resistance Level $6.64 $3.57
Average True Range (ATR) 0.20 0.21
MACD -0.07 0.03
Stochastic Oscillator 8.00 60.69

Price Performance

Historical Comparison
SITC
ABCL

About SITC SITE Centers Corp.

SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: